A bipartisan House proposal would bring federal FDA rules to CBD and certain hemp derived products, replacing today’s patchwork. Here is what it means for labeling, testing, distribution, and competition with licensed cannabis.

New research suggests legalization is expanding legal cannabis demand by drawing in more women and older adults. For operators, that means product formats, dosing clarity, and education first retail matter more than ever.

Federal seizures can still impact licensed cannabis businesses, even when they follow state rules. Here is why it happens, where operators get exposed, and how to reduce federal friction before it turns into inventory loss.

Cannabis M&A is still happening, just quieter and more disciplined. Here is why deals moved behind closed doors, what buyers are targeting, and how operators can stay deal ready without getting crushed on terms.

Another discounted asset sale signals accelerating consolidation in California’s cannabis market. Distressed operators are exiting as capitalized buyers position for long-term efficiency and scale.

Despite federal reclassification, cannabis businesses still face major barriers accessing traditional banking services. Large financial institutions remain cautious, forcing operators to rely on smaller lenders and alternative financing.

New York’s average cannabis price dropped from $38.61 to $32.15 as licensed store openings and expanded product selection increased competition. This decline shows the market is maturing — but it also raises new challenges for operators navigating shrinking margins and rising compliance pressure.

A new Oregon study finds that adults living near licensed cannabis stores report less heavy drinking and more marijuana use, especially among Gen Z and Baby Boomers. The findings suggest cannabis access may be replacing alcohol as a preferred wellness or social alternative.

A major edible-fruit brand is launching hemp-derived THC gummies and beverages aimed at wellness consumers seeking alcohol-free relaxation. The move highlights how mainstream companies are entering the cannabis ecosystem amid evolving regulations and rising consumer demand.

Receiverships are often misunderstood in cannabis, but they can provide struggling operators with a path to stability and compliance. Learn how this legal tool can protect licenses, preserve value, and set businesses up for long-term survival.

The FDA has begun actively tracking adverse health events linked to hemp and CBD products. This new reporting process marks a step toward greater federal oversight and signals important changes ahead for operators, investors, and consumers.